The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts.

It is widely accepted that disorders of the male (uro)genital tract, such as erectile dysfunction (ED) and benign diseases of the prostate (lower urinary tract symptomatology or benign prostatic hyperplasia), can be approached therapeutically by influencing the function of both the vascular and non-vascular smooth muscle of the penile erectile tissue or the transition zone/periurethral […]

Angiographic prostatic arterial anatomy in Turkish population with benign prostatic hyperplasia.

Background and Aim Prostatic artery embolization (PAE) is a minimal invasive effective method in the treatment of benign prostatic hyperplasia (BPH). The procedure is technically challenging as pelvic vascular anatomy is highly prone to variations and identification of the prostatic artery (PA) is the most time consuming step which can lead to increased procedure times.

Patients with benign prostatic hyperplasia show shorter leukocyte telomere length but no association with telomerase gene polymorphisms in Han Chinese males.

Benign prostatic hyperplasia (BPH) is an age-related disease, occurring in >70% of men of age >60. Because telomeres and telomerase play a key role in aging and age-related diseases, and certain telomerase gene single nucleotide polymorphisms (SNPs) are shown to be associated with the susceptibility to age-related diseases, we wanted to determine the relationship between […]

X